Madsen F A, Bruskewitz R C
Division of Urology, University of Wisconsin Hospital and Clinics, Madison, USA.
Curr Opin Nephrol Hypertens. 1995 Sep;4(5):455-9. doi: 10.1097/00041552-199509000-00015.
Recent studies have confirmed that alpha-blocker therapy and antihormonal therapy are effective and safe treatment modalities in patients with symptomatic benign prostatic hyperplasia. New data suggest that the clinical response to medical therapy lasts for at least 3 years without any increase in side effects during this period.
